398 related articles for article (PubMed ID: 25522423)
41. Do patients with schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the Beliefs About Medication Questionnaire.
Beck EM; Vögelin R; Wirtz M; Cavelti M; Kvrgic S; Vauth R
J Nerv Ment Dis; 2012 Jan; 200(1):33-43. PubMed ID: 22210360
[TBL] [Abstract][Full Text] [Related]
42. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
43. Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.
Ciudad A; San L; Bernardo M; Olivares JM; Polavieja P; Valladares A; Gilaberte I
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):245-50. PubMed ID: 22056291
[TBL] [Abstract][Full Text] [Related]
44. Novelty seeking and medication adherence in patients with schizophrenia.
Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
[TBL] [Abstract][Full Text] [Related]
45. A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: depot versus oral.
Patel MX; de Zoysa N; Bernadt M; David AS
J Clin Psychiatry; 2008 Oct; 69(10):1548-56. PubMed ID: 19192437
[TBL] [Abstract][Full Text] [Related]
46. Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients.
Tranulis C; Goff D; Henderson DC; Freudenreich O
Psychiatr Serv; 2011 Aug; 62(8):888-92. PubMed ID: 21807827
[TBL] [Abstract][Full Text] [Related]
47. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
48. Attitudes toward antipsychotic medication, insight and psychopathology in outpatients with schizophrenia.
Vassileva IV; Milanova VK
Folia Med (Plovdiv); 2012; 54(4):62-8. PubMed ID: 23441471
[TBL] [Abstract][Full Text] [Related]
49. Treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
[TBL] [Abstract][Full Text] [Related]
50. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
51. Attitudes to Medication-Treatment Among Patients and Caregivers: A Longitudinal Comparison of Bipolar Disorder and Schizophrenia From India.
Chauhan N; Chakrabarti S; Grover S
J Clin Psychopharmacol; 2020; 40(1):18-29. PubMed ID: 31804452
[TBL] [Abstract][Full Text] [Related]
52. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
53. Reasons for adherence and nonadherence: a pilot study comparing first- and multi-episode schizophrenia patients.
Sapra M; Weiden PJ; Schooler NR; Sunakawa-McMillan A; Uzenoff S; Burkholder P
Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):199-206. PubMed ID: 23428784
[TBL] [Abstract][Full Text] [Related]
54. Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients.
Hashimoto Y; Uno J; Miwa T; Kurihara M; Tanifuji H; Tensho M
Psychiatry Clin Neurosci; 2012 Aug; 66(5):405-10. PubMed ID: 22834658
[TBL] [Abstract][Full Text] [Related]
55. The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.
Subotnik KL; Ventura J; Gretchen-Doorly D; Hellemann GS; Agee ER; Casaus LR; Luo JS; Villa KF; Nuechterlein KH
Schizophr Res; 2014 Oct; 159(1):95-100. PubMed ID: 25108771
[TBL] [Abstract][Full Text] [Related]
56. Improving treatment adherence in patients with schizophrenia.
Kane JM
J Clin Psychiatry; 2011 Sep; 72(9):e28. PubMed ID: 21951990
[TBL] [Abstract][Full Text] [Related]
57. Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs - A study based on blood sample analyses from 24,239 patients.
Smith RL; Tveito M; Kyllesø L; Jukic MM; Ingelman-Sundberg M; Andreassen OA; Molden E
Eur Neuropsychopharmacol; 2020 Aug; 37():64-69. PubMed ID: 32595082
[TBL] [Abstract][Full Text] [Related]
58. A pilot study of barriers to medication adherence in schizophrenia.
Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
[TBL] [Abstract][Full Text] [Related]
59. Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.
Chen KP; Lung FW
Psychiatr Q; 2017 Dec; 88(4):787-796. PubMed ID: 28150091
[TBL] [Abstract][Full Text] [Related]
60. [Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications].
Misdrahi D; Llorca PM; Lançon C; Bayle FJ
Encephale; 2002; 28(3 Pt 1):266-72. PubMed ID: 12091789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
